| __timestamp | Geron Corporation | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 20707000 | 855506000 |
| Thursday, January 1, 2015 | 17831000 | 996170000 |
| Friday, January 1, 2016 | 18047000 | 1047690000 |
| Sunday, January 1, 2017 | 11033000 | 1324625000 |
| Monday, January 1, 2018 | 13432000 | 1416476000 |
| Tuesday, January 1, 2019 | 52072000 | 1754540000 |
| Wednesday, January 1, 2020 | 51488000 | 1829537000 |
| Friday, January 1, 2021 | 85727000 | 3051100000 |
| Saturday, January 1, 2022 | 95518000 | 2540300000 |
| Sunday, January 1, 2023 | 125046000 | 3162900000 |
| Monday, January 1, 2024 | 3630300000 |
In pursuit of knowledge
In the competitive world of biotechnology, innovation is key. Vertex Pharmaceuticals Incorporated and Geron Corporation are two prominent players, each with a unique approach to research and development (R&D). Over the past decade, Vertex has consistently outpaced Geron in R&D spending, investing nearly 20 times more on average. In 2023, Vertex's R&D expenses reached a staggering $3.16 billion, marking a 270% increase since 2014. In contrast, Geron's investment, while growing, peaked at $125 million in 2023, a sixfold increase from 2014.
From 2014 to 2023, Vertex's commitment to innovation is evident, with a steady increase in R&D spending, reflecting its strategic focus on developing groundbreaking therapies. Geron, while smaller in scale, has shown a significant upward trend, particularly in recent years, indicating a renewed focus on innovation. This data highlights the varying scales and strategies of these two biotech giants.
Research and Development Expenses Breakdown: Novartis AG vs Geron Corporation
Pfizer Inc. vs Geron Corporation: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Ascendis Pharma A/S
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Soleno Therapeutics, Inc.
R&D Insights: How Vertex Pharmaceuticals Incorporated and Xencor, Inc. Allocate Funds
Zoetis Inc. or Geron Corporation: Who Invests More in Innovation?
United Therapeutics Corporation or Geron Corporation: Who Invests More in Innovation?
Insmed Incorporated vs Geron Corporation: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Exelixis, Inc. and Geron Corporation
Analyzing R&D Budgets: Ligand Pharmaceuticals Incorporated vs Geron Corporation
Research and Development Investment: Geron Corporation vs BioCryst Pharmaceuticals, Inc.